Innovation Pharmaceuticals presented both topline findings from the completed Brilacidin-UP/UPS trial and interim data from its ongoing Phase 2 trial of Brilacidin for Oral Mucositis at the Drug Discovery and Therapy World Congress 2017 on July 13, 2017 in Boston.

The DDTWC presentation slide deck can be accessed by clicking here (pdf).